Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Calcif Tissue Int ; 68(3): 151-5, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11351498

ABSTRACT

Paget's disease of bone (PDB) is a common disorder characterized by focal areas of increased and disorganized osteoclastic bone resorption, leading to bone pain, deformity, pathological fracture, and an increased risk of osteosarcoma. Genetic factors play an important role in the pathogenesis of Paget's disease. In some families, the disease has been found to be linked to a susceptibility locus on chromosome 18q21-22, which also contains the gene responsible for familial expansile osteolysis (FEO)--a rare bone dysplasia with many similarities to Paget's disease. Insertion mutations of the TNFRSF11A gene encoding Receptor Activator of NF kappa B (RANK) have recently been found to be responsible for FEO and rare cases of early onset familial Paget's disease. Loss of heterozygosity (LOH) affecting the PDB/FEO critical region has also been described in osteosarcomas suggesting that TNFRSF11A might also be involved in the development of osteosarcoma. In order to investigate the possible role of TNFRSF11A in the pathogenesis of Paget's disease and osteosarcoma, we conducted mutation screening of the TNFRSF11A gene in patients with familial and sporadic Paget's disease as well as DNA extracted from Pagetic bone lesions, an osteosarcoma arising in Pagetic bone and six osteosarcoma cell lines. No specific abnormalities of the TNFRSF11A gene were identified in a Pagetic osteosarcoma, the osteosarcoma cell lines, DNA extracted from Pagetic bone lesions, or DNA extracted from peripheral blood in patients with familial or sporadic Paget's disease including several individuals with early onset Paget's disease. These data indicate that TNFRSF11A mutations contribute neither to the vast majority of cases of sporadic or familial PDB, nor to the development of osteosarcoma.


Subject(s)
Bone Neoplasms/genetics , Genetic Predisposition to Disease , Glycoproteins/genetics , Osteitis Deformans/genetics , Osteosarcoma/genetics , Receptors, Cytoplasmic and Nuclear/genetics , Adult , DNA/analysis , DNA Mutational Analysis , DNA Primers/chemistry , Genetic Testing , Humans , Osteoprotegerin , Point Mutation , Polymerase Chain Reaction , Receptors, Tumor Necrosis Factor
2.
Am J Pathol ; 156(1): 37-43, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10623651

ABSTRACT

DPC4 (MADH4, SMAD4) is a tumor suppressor gene inactivated by allelic loss in approximately 55% of pancreatic adenocarcinomas. Unfortunately, it can be technically very difficult to detect the inactivation of DPC4 at the genetic level because genetic analyses require the microdissection of relatively pure samples of neoplastic and normal tissues. This is especially true for pancreatic adenocarcinomas, which elicit vigorous, non-neoplastic, stromal responses. Immunohistochemical labeling can overcome this hurdle because it preserves morphological information. We therefore studied the expression of the DPC4 gene product in 46 cancers, including 5 cancer cell lines by Western blot analysis and 41 primary periampullary adenocarcinomas by immunohistochemistry. The status of exons 1-11 of the DPC4 gene in all 46 of the cancers had been previously characterized at the molecular level, allowing us to correlate Dpc4 expression directly with gene status. Three cell lines had wild-type DPC4 genes, and Dpc4 expression was detected in all three by Western blot. The two cell lines with homozygously deleted DPC4 genes did not show Dpc4 protein by Western blot analysis. Immunohistochemical labeling revealed that 17 (94%) of the 18 primary adenocarcinomas with wild-type DPC4 genes expressed the DPC4 gene product, whereas 21 (91%) of 23 primary adenocarcinomas with inactivated DPC4 genes did not. Cases in which there was discordance between the immunohistochemical labeling and the genetic analyses were reanalyzed genetically, and we identified a deletion in exon 0 of DPC4 in one of these cases. This is the first report of a mutation in exon 0 of DPC4 in a pancreatic cancer. The contrast between the strong expression of Dpc4 by normal tissues and the loss of expression in the carcinomas was highlighted in several cases in which an infiltrating cancer was identified growing into a benign duct. These observations suggest that immunohistochemical labeling for the DPC4 gene product is an extremely sensitive and specific marker for DPC4 gene alterations in pancreatic carcinomas. The sensitivity and specificity of immunohistochemical labeling for Dpc4 in other periampullary carcinomas has yet to be determined.


Subject(s)
Adenocarcinoma/genetics , Adenocarcinoma/metabolism , DNA-Binding Proteins/metabolism , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/metabolism , Trans-Activators/metabolism , Adenocarcinoma/pathology , Biomarkers , Blotting, Western , Gene Expression Regulation/physiology , Humans , Immunohistochemistry , Pancreatic Neoplasms/pathology , Sensitivity and Specificity , Smad4 Protein
3.
Oncogene ; 18(35): 5010-4, 1999 Sep 02.
Article in English | MEDLINE | ID: mdl-10490837

ABSTRACT

The majority of human colorectal cancers have elevated beta-catenin/TCF regulated transcription due to either inactivating mutations of the APC tumor suppressor gene or activating mutations of beta-catenin. Surprisingly, one commonly used colorectal cancer cell line was found to have intact APC and beta-catenin and no demonstrable beta-catenin/TCF regulated transcription. However, this line did possess a truncating mutation in one allele of CDX2, a gene whose inactivation has recently been shown to cause colon tumorigenesis in mice. Expression of CDX2 was found to be induced by restoring expression of wild type APC in a colorectal cancer cell line. These findings raise the intriguing possibility that CDX2 contributes to APC's tumor suppressive effects.


Subject(s)
Colorectal Neoplasms/genetics , Cytoskeletal Proteins/metabolism , Gene Expression Regulation, Neoplastic , Homeodomain Proteins/genetics , Mutation , Trans-Activators , Adenomatous Polyposis Coli Protein , Alleles , CDX2 Transcription Factor , Colorectal Neoplasms/metabolism , Cytoskeletal Proteins/genetics , DNA Mutational Analysis , Genes, Tumor Suppressor/genetics , Genes, Tumor Suppressor/physiology , Homeodomain Proteins/metabolism , Homeostasis , Humans , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction , Transcriptional Activation , Transfection , Tumor Cells, Cultured , beta Catenin
4.
Science ; 281(5382): 1509-12, 1998 Sep 04.
Article in English | MEDLINE | ID: mdl-9727977

ABSTRACT

The adenomatous polyposis coli gene (APC) is a tumor suppressor gene that is inactivated in most colorectal cancers. Mutations of APC cause aberrant accumulation of beta-catenin, which then binds T cell factor-4 (Tcf-4), causing increased transcriptional activation of unknown genes. Here, the c-MYC oncogene is identified as a target gene in this signaling pathway. Expression of c-MYC was shown to be repressed by wild-type APC and activated by beta-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter. These results provide a molecular framework for understanding the previously enigmatic overexpression of c-MYC in colorectal cancers.


Subject(s)
Colorectal Neoplasms/genetics , Gene Expression Regulation, Neoplastic , Genes, APC , Genes, myc , Trans-Activators , Adenomatous Polyposis Coli Protein , Binding Sites , Cell Line , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Genes, Reporter , HT29 Cells , Humans , Mutation , Promoter Regions, Genetic , Proto-Oncogene Proteins c-myc/metabolism , Signal Transduction , TCF Transcription Factors , Transcription Factor 7-Like 2 Protein , Transcription Factors/metabolism , Transcription, Genetic , beta Catenin
6.
Cancer Res ; 58(6): 1130-4, 1998 Mar 15.
Article in English | MEDLINE | ID: mdl-9515795

ABSTRACT

Mutation of the adenomatous polyposis coli (APC) tumor suppressor gene initiates the majority of colorectal (CR) cancers. One consequence of this inactivation is constitutive activation of beta-catenin/Tcf-mediated transcription. To further explore the role of the APC/beta-catenin/Tcf pathway in CR tumorigenesis, we searched for mutations in genes implicated in this pathway in CR tumors lacking APC mutations. No mutations of the gamma-catenin (CTNNG1), GSK-3alpha (GSK3A), or GSK-3beta (GSK3B) genes were detected. In contrast, mutations in the NH2-terminal regulatory domain of beta-catenin (CTNNB1) were found in 13 of 27 (48%) CR tumors lacking APC mutations. Mutations in the beta-catenin regulatory domain and APC were observed to be mutually exclusive, consistent with their equivalent effects on beta-catenin stability and Tcf transactivation. In addition, we found that CTNNB1 mutations can occur in the early, adenomatous stage of CR neoplasia, as has been observed previously with APC mutations. These results suggest that CTNNB1 mutations can uniquely substitute for APC mutations in CR tumors and that beta-catenin signaling plays a critical role in CR tumorigenesis.


Subject(s)
Adenocarcinoma/genetics , Adenoma/genetics , Colorectal Neoplasms/genetics , Cytoskeletal Proteins/genetics , Genes, APC , Trans-Activators , Amino Acid Sequence , DNA Mutational Analysis , Desmoplakins , Humans , Molecular Sequence Data , Mutation , Sequence Alignment , TCF Transcription Factors , Transcription Factor 7-Like 2 Protein , Transcription Factors/genetics , beta Catenin , gamma Catenin
7.
J Biol Chem ; 272(23): 14611-6, 1997 Jun 06.
Article in English | MEDLINE | ID: mdl-9169421

ABSTRACT

A recently described protein module consisting of 35-40 semiconserved residues, termed the WW domain, has been identified in a number of diverse proteins including dystrophin and Yes-associated protein (YAP). Two putative ligands of YAP, termed WBP-1 and WBP-2, have been found previously to contain several short peptide regions consisting of PPPPY residues (PY motif) that mediate binding to the WW domain of YAP. Although the function(s) of the WW domain remain to be elucidated, these observations strongly support a role for the WW domain in protein-protein interactions. Here we report the isolation of three novel human cDNAs encoding a total of nine WW domains, using a newly developed approach termed COLT (cloning of ligand targets), in which the rapid cloning of modular protein domains is accomplished by screening cDNA expression libraries with specific peptide ligands. Two of the new genes identified appear to be members of a family of proteins, including Rsp5 and Nedd-4, which have ubiquitin-protein ligase activity. In addition, we demonstrate that peptides corresponding to PY and PY-like motifs present in several known signaling or regulatory proteins, including RasGAP, AP-2, p53BP-2 (p53-binding protein-2), interleukin-6 receptor-alpha, chloride channel CLCN5, and epithelial sodium channel ENaC, can selectively bind to certain of these novel WW domains.


Subject(s)
Dystrophin/chemistry , Ligands , Amino Acid Sequence , Animals , Binding Sites , Cloning, Molecular/methods , Conserved Sequence , DNA, Complementary , Gene Library , Humans , Molecular Sequence Data , Rats , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry
8.
Biol Chem ; 378(6): 531-7, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9224934

ABSTRACT

The WW domain is a globular protein domain that is involved in mediating protein-protein interaction and that ultimately participates in various intracellular signaling events. The domain binds to polyproline ligands containing the xPPxY consensus (where x signifies any amino acid, P is proline and Y is tyrosine). One of the first WW domain-ligand links that was characterized in vitro was the WW domain of Yes-Associated Protein (YAP) and its WBP-1 ligand. To further characterize this molecular interaction, we used two independent approaches, both of which focused on the mutational analysis of the WBP-1 ligand. We screened repertoires of synthetic decamer peptides containing the xPPxY core of WBP-1 in which all ten positions were sequentially replaced with the remaining amino acids. In addition, we screened decamer repertoires with all permutations of the amino acids which individually increased the binding to the WW domain of YAP, as compared to the wild type. In a parallel approach, we used a phage-displayed combinatorial peptide library biased for the presence of two consecutive prolines to study ligand preferences for the WW domain of YAP. Interestingly, these two lines of investigation converged and yielded the core sequence PPPPYP, which is preferred by the YAP-WW domain. This sequence was found within the p53 (tumor suppressor) binding protein-2, a probable cognate or alternative ligand interacting with YAP.


Subject(s)
Adaptor Proteins, Signal Transducing , Carrier Proteins/metabolism , Peptides/metabolism , Phosphoproteins/metabolism , Protein Structure, Tertiary , Amino Acid Sequence , Animals , Apoptosis Regulatory Proteins , Bacteriophages/chemistry , Bacteriophages/genetics , Bacteriophages/metabolism , Carrier Proteins/chemistry , Cell Cycle Proteins , Computational Biology , Humans , Intracellular Signaling Peptides and Proteins , Ligands , Mice , Molecular Sequence Data , Mutagenesis , Peptide Library , Phosphoproteins/chemistry , Protein Binding , Transcription Factors , YAP-Signaling Proteins
9.
Science ; 275(5307): 1787-90, 1997 Mar 21.
Article in English | MEDLINE | ID: mdl-9065402

ABSTRACT

Inactivation of the adenomatous polyposis coli (APC) tumor suppressor gene initiates colorectal neoplasia. One of the biochemical activities associated with the APC protein is down-regulation of transcriptional activation mediated by beta-catenin and T cell transcription factor 4 (Tcf-4). The protein products of mutant APC genes present in colorectal tumors were found to be defective in this activity. Furthermore, colorectal tumors with intact APC genes were found to contain activating mutations of beta-catenin that altered functionally significant phosphorylation sites. These results indicate that regulation of beta-catenin is critical to APC's tumor suppressive effect and that this regulation can be circumvented by mutations in either APC or beta-catenin.


Subject(s)
Colonic Neoplasms/genetics , Cytoskeletal Proteins/genetics , Cytoskeletal Proteins/metabolism , Genes, APC , Trans-Activators , Transcription Factors/metabolism , Transcription, Genetic , Adenomatous Polyposis Coli Protein , Colonic Neoplasms/metabolism , Gene Expression Regulation, Neoplastic , Genes, Reporter , Germ-Line Mutation , Humans , Mutation , Phosphorylation , Signal Transduction , TCF Transcription Factors , Transcription Factor 7-Like 2 Protein , Transfection , Tumor Cells, Cultured , beta Catenin
10.
J Biol Chem ; 271(46): 28772-6, 1996 Nov 15.
Article in English | MEDLINE | ID: mdl-8910519

ABSTRACT

The NCK adapter protein is comprised of three consecutive Src homology 3 (SH3) protein-protein interaction domains and a C-terminal SH2 domain. Although the association of NCK with activated receptor protein-tyrosine kinases, via its SH2 domain, implicates NCK as a mediator of growth factor-induced signal transduction, little is known about the pathway(s) downstream of NCK recruitment. To identify potential downstream effectors of NCK we screened a bacterial expression library to isolate proteins that bind its SH3 domains. Two molecules were isolated, the Wiskott-Aldrich syndrome protein (WASP, a putative CDC42 effector) and a serine/threonine protein kinase (PRK2, closely related to the putative Rho effector PKN). Using interspecific backcross analysis the Prk2 gene was mapped to mouse chromosome 3. Unlike WASP, which bound the SH3 domains of several signaling proteins, PRK2 specifically bound to the middle SH3 domain of NCK and (weakly) that of phospholipase Cgamma. PRK2 also specifically bound to Rho in a GTP-dependent manner and cooperated with Rho family proteins to induce transcriptional activation via the serum response factor. These data suggest that PRK2 may coordinately mediate signal transduction from activated receptor protein-tyrosine kinases and Rho and that NCK may function as an adapter to connect receptor-mediated events to Rho protein signaling.


Subject(s)
GTP-Binding Proteins/metabolism , Protein Kinase C/isolation & purification , Signal Transduction , 3T3 Cells , Amino Acid Sequence , Animals , Female , Gene Expression Regulation, Enzymologic , Male , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Protein Binding , Protein Kinase C/metabolism , Proteins/metabolism , Transcription, Genetic , Wiskott-Aldrich Syndrome/metabolism , Wiskott-Aldrich Syndrome Protein , src Homology Domains
11.
Mol Divers ; 2(1-2): 5-12, 1996 Oct.
Article in English | MEDLINE | ID: mdl-9238627

ABSTRACT

Combinatorial libraries have yielded high-affinity ligands for SH3 domains of a number of different proteins. We have shown that synthetic peptides containing these SH3 ligand sequences serve as specific probes of SH3 domains. Direct binding of the N-terminal biotinylated peptide ligands was conveniently detected in ELISA, filter-blotting, and dot-blotting experiments with the use of streptavidin-conjugated enzymes. In some cases, detection of peptide-SH3 interactions required that the biotinylated peptides first were preconjugated with streptavidin to form a multivalent complex. Interestingly, these nominally tetravalent SH3 peptide ligands cross-react to varying degrees with different SH3 domains. We have used such complexes to screen lambda cDNA expression libraries and have isolated clones that encode both known and novel SH3-domain-containing proteins. Based on the success of this methodology, we propose a general strategy by which ligands of a modular domain-containing protein can be isolated from random peptide libraries and used to screen cDNA expression libraries systematically for novel modular domain-containing proteins.


Subject(s)
Bacteriophage lambda/metabolism , Peptide Fragments/metabolism , Peptide Library , src Homology Domains , Amino Acid Sequence , Animals , Bacteriophage lambda/genetics , Cloning, Molecular , Mice , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/genetics , Protein Binding/genetics , src Homology Domains/genetics
12.
Nat Biotechnol ; 14(6): 741-4, 1996 Jun.
Article in English | MEDLINE | ID: mdl-9630982

ABSTRACT

Based on the prevalence of modular protein domains, such as Src homology domain 3 and 2 (SH3 and SH2), among important signaling molecules, we have sought to identify new SH3 domain-containing proteins. However, modest sequence similarity among these domains restricts the use of DNA-based methods for this purpose. To circumvent this limitation, we have developed a functional screen that permits the rapid cloning of modular domains based on their ligand-binding activity. Using operationally defined SH3 ligands from combinatorial peptide libraries, we screened a series of mouse and human cDNA expression libraries. We found that 69 of the 74 clones isolated encode at least one SH3 domain. These clones encode 18 different SH3-containing proteins, 10 of which have not been described previously. The isolation of entire repertoires of modular domain-containing proteins will prove invaluable in genome analysis and in bringing new targets into drug discovery programs.


Subject(s)
Proteins/genetics , src Homology Domains , Amino Acid Sequence , Animals , Cloning, Molecular , Humans , Ligands , Mice , Molecular Sequence Data , Protein Binding , Proteins/chemistry , Proteins/metabolism , Sequence Homology, Amino Acid
13.
Proc Natl Acad Sci U S A ; 93(4): 1540-4, 1996 Feb 20.
Article in English | MEDLINE | ID: mdl-8643668

ABSTRACT

Src homology 3 (SH3) domains are conserved protein modules 50-70 amino acids long found in a variety of proteins with important roles in signal transduction. These domains have been shown to mediate protein-protein interactions by binding short proline-rich regions in ligand proteins. However, the ligand preferences of most SH3 domains and the role of these preferences in regulating SH3-mediated protein-protein interactions remain poorly defined. We have used a phage-displayed library of peptides of the form X6PXXPX6 to identify ligands for eight different SH3 domains. Using this approach, we have determined that each SH3 domain prefers peptide ligands with distinct sequence characteristics. Specifically, we have found that the Src SH3 domain selects peptides sharing the consensus motif LXXRPLPXpsiP, whereas Yes SH3 selects psiXXRPLPXLP, Abl SH3 selects PPXthetaXPPPpsiP, Cortactin SH3 selects +PPpsiPXKPXWL, p53bp2 SH3 selects RPXpsiPpsiR+SXP, PLCgamma SH3 selects PPVPPRPXXTL, Crk N-terminal SH3 selects psiPpsiLPpsiK, and Grb2 N-terminal SH3 selects +thetaDXPLPXLP (where psi, theta, and + represent aliphatic, aromatic, and basic residues, respectively). Furthermore, we have compared the binding of phage expressing peptides related to each consensus motif to a panel of 12 SH3 domains. Results from these experiments support the ligand preferences identified in the peptide library screen and evince the ability of SH3 domains to discern subtle differences in the primary structure of potential ligands. Finally, we have found that most known SH3-binding proteins contain proline-rich regions conforming to the ligand preferences of their respective SH3 targets.


Subject(s)
Adaptor Proteins, Signal Transducing , Peptides/metabolism , Signal Transduction , src Homology Domains , src-Family Kinases , Amino Acid Sequence , Apoptosis Regulatory Proteins , Carrier Proteins/metabolism , Consensus Sequence , Cortactin , GRB2 Adaptor Protein , Isoenzymes/metabolism , Ligands , Microfilament Proteins/metabolism , Molecular Sequence Data , Peptides/chemistry , Phospholipase C gamma , Protein Binding , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-abl/metabolism , Proto-Oncogene Proteins c-crk , Proto-Oncogene Proteins c-yes , Proto-Oncogene Proteins pp60(c-src)/metabolism , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , Type C Phospholipases/metabolism
15.
J Biol Chem ; 269(39): 23853-6, 1994 Sep 30.
Article in English | MEDLINE | ID: mdl-7929027

ABSTRACT

We have used the Src homology 3 (SH3) domain to screen two phage-displayed random peptide libraries, each containing 2 x 10(8) unique members, and have identified a series of high affinity peptide ligands. The peptides possess similar proline-rich regions, which yield a consensus Src SH3-binding motif of RPLPPLP. We have confirmed this motif by screening a phage-displayed peptide library biased for SH3 ligands and identifying the same consensus sequence. Binding studies using synthetic peptides suggest that the RPLPPLP motif is important for SH3 binding and confers specificity for the Src SH3 domain, and that residues which flank the motif may also contribute to binding. Peptides that contain the RPLPPLP motif compete Src, but not Abl or phospholipase C gamma, SH3 interactions with SH3-binding proteins from cell lysates (IC50 = 1-5 microM). Furthermore, RPLPPLP-related peptides are able to accelerate progesterone-induced maturation of Xenopus laevis oocytes. A similar acceleration has been observed in oocytes treated with activated, but not normal, Xenopus Src, suggesting the possibility that the peptides are able to antagonize the negative regulation of Src activity by Src SH3 in vivo.


Subject(s)
Bacteriophages/metabolism , Oncogene Protein pp60(v-src)/metabolism , 3T3 Cells , Amino Acid Sequence , Animals , Ligands , Mice , Molecular Sequence Data , Protein Binding , Xenopus laevis
16.
Proc Natl Acad Sci U S A ; 91(4): 1569-73, 1994 Feb 15.
Article in English | MEDLINE | ID: mdl-8108446

ABSTRACT

The F-type subfamily of LINE-1 or L1 retroposons [for long interspersed (repetitive) element 1] was dispersed in the mouse genome several million years ago. This subfamily appears to be both transcriptionally and transpositionally inactive today and therefore may be considered evolutionarily extinct. We hypothesized that these F-type L1s are inactive because of the accumulation of mutations. To test this idea we used phylogenetic analysis to deduce the sequence of a transpositionally active ancestral F-type promoter, resurrected it by chemical synthesis, and showed that it has promoter activity. In contrast, F-type sequences isolated from the modern genome are inactive. This approach, in which the automated DNA synthesizer is used as a "time machine," should have broad application in testing models derived from evolutionary studies.


Subject(s)
Biological Evolution , DNA Transposable Elements/genetics , Promoter Regions, Genetic/genetics , Animals , Base Sequence , Cells, Cultured , Chloramphenicol O-Acetyltransferase/biosynthesis , Chloramphenicol O-Acetyltransferase/genetics , Consensus Sequence , Mice , Molecular Sequence Data , Mutation , Phylogeny , Recombinant Fusion Proteins/biosynthesis , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...